Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Jenner Biotherapies receives patent protection for JBT-3002, a novel macrophage activator

Aug. 6, 1999

MacroChem reports results of safety trials with Topiglan

Aug. 6, 1999

Women First to market Fournier's estradiol patch in U.S.

Aug. 6, 1999

INSERM describes TPP II inhibitors and their use in treating eating disorders, obesity

Aug. 5, 1999

SB team identifies bone resorption inhibitors selective for mammalian osteoclasts

Aug. 5, 1999

First launch for bile acid-sequestering agent colestimide

Aug. 5, 1999

GAD65 peptides prevent diabetes in mouse model

Aug. 5, 1999

Novo Nordisk synthesizes potassium channel modulators for endocrine diseases

Aug. 4, 1999

Unigene awarded U.S. patent for oral calcitonin product

Aug. 4, 1999

GelTex seeks FDA approval of Cholestagel

Aug. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...